International Journal of Thyroidology

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2466-1899   pISSN 2384-3799

Table. 1.

Table. 1.

Baseline characteristics of the study population (n=115)

Variable Value
Age, years (mean±SD) 50.22±14.24
Sex, female (%) 72 (62.6)
Size, cm (mean±SD) 1.89±1.46
Multifocal tumors, number (%) 23 (20.0)
Bilateral tumors, number (%) 18 (15.7)
RET mutation, number (%)
Positive 16/76
(21.1)
Negative 60/76
(78.9)
T stage, number (%)
1a 40 (34.8)
1b 27 (23.5)
2 19 (16.5)
3a 7 (6.1)
3b 13 (11.3)
4a 9 (7.8)
N stage, number (%)
0 47 (40.9)
1a 18 (15.6)
1b 50 (43.5)
AJCC 8th stage, number (%)
I 37 (32.2)
II 10 (8.7)
III 18 (15.6)
IVA 50 (43.5)
Preoperative serum calcitonin, pg/mL
Mean 1,188
Median 336
Range 4-17,200
Preoperative serum CEA, ng/mL
Mean 32.3
Median 6.4
Range 0.5-475.7
Follow-up duration, years
Median (IQR) 8.3
(4.9-10.8)
Clinical outcome, number (%)
No evidence of structural recurrence confirmed by sonography 80 (69.6%)
Local metastasis confined to neck lymph nodes 15 (13.0%)
Distant metastasis confirmed by CT or PET scans 13 (11.3%)
Death 7 (6.1%)

AJCC: American Joint Committee on Cancer, CEA: carcinoembryonic antigen, CT: computerized tomography, IQR: interquartile range, MTC: medullary thyroid carcinoma, PET: positron emission tomography, SD: standard deviation

Int J Thyroidol 2021;14:143-51 https://doi.org/10.11106/ijt.2021.14.2.143
© 2021 Int J Thyroidol